{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:17:29Z","timestamp":1790965049701,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8G0501"],"award-info":[{"award-number":["CMRPG8G0501"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Primary Sj\u00f6gren\u2019s syndrome (pSS) is associated with dental caries. Pilocarpine, a salivary stimulant, can improve the amount and flow rate of saliva in patients with pSS. This study aimed to assess whether the risk of dental caries decreases with the use of pilocarpine in patients with pSS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>For this prospective cohort study, we identified pSS patients from the catastrophic illnesses registry of the National Health Insurance Research Database of Taiwan between 2009 and 2013. We divided participants into pilocarpine and non-user groups based on the pilocarpine prescriptions available during the first 3-month follow-up. The primary endpoint was dental caries. The secondary endpoints were periodontitis and oral candidiasis. We compared the risk of these oral manifestations using the Cox proportional hazard model.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 4973 patients with new-onset pSS were eligible for analysis. After propensity score matching, we included 1014 patients in the pilocarpine group and 2028 patients in the non-user group. During the mean follow-up of 2.6\u2009years, the number of events was 487 in the pilocarpine group (48.0%) and 1047 in the non-user group (51.6%); however, the difference was not significant (hazard ratio [HR] 0.93, 95% confidence interval [CI] 0.82 to 1.06). Furthermore, there was no significant difference between groups regarding risk of periodontitis (HR 0.91, 95% CI 0.81 to 1.03) and oral candidiasis (HR 1.16, 95% CI 0.70 to 1.94).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Pilocarpine may have no protective effect on dental caries, periodontitis, or oral candidiasis in patients with pSS.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13075-019-2031-7","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T13:02:34Z","timestamp":1574859754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The effect of pilocarpine on dental caries in patients with primary Sj\u00f6gren\u2019s syndrome: a database prospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Chung-Yuan","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chun","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hua","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"2031_CR1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sjogren syndrome. Nat Rev Dis Primers. 2016;2:16047.","journal-title":"Nat Rev Dis Primers"},{"key":"2031_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/000163501750266684","volume":"59","author":"LB Christensen","year":"2001","unstructured":"Christensen LB, Petersen PE, Thorn JJ, Schiodt M. Dental caries and dental health behavior of patients with primary Sjogren syndrome. Acta Odontol Scand. 2001;59:116\u201320.","journal-title":"Acta Odontol Scand"},{"key":"2031_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1034\/j.1600-051X.2002.291108.x","volume":"29","author":"L Jansson","year":"2002","unstructured":"Jansson L, Lavstedt S, Frithiof L. Relationship between oral health and mortality rate. J Clin Periodontol. 2002;29:1029\u201334.","journal-title":"J Clin Periodontol"},{"key":"2031_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1177\/154405910208101202","volume":"81","author":"J Tenovuo","year":"2002","unstructured":"Tenovuo J. Antimicrobial agents in saliva--protection for the whole body. J Dent Res. 2002;81:807\u20139.","journal-title":"J Dent Res"},{"key":"2031_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"FB Vivino","year":"2016","unstructured":"Vivino FB, Carsons SE, Foulks G, Daniels TE, Parke A, Brennan MT, et al. New treatment guidelines for Sjogren's disease. Rheum Dis Clin N Am. 2016;42:531\u201351.","journal-title":"Rheum Dis Clin N Am"},{"key":"2031_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/00220345940730030901","volume":"73","author":"AC O'Connell","year":"1994","unstructured":"O'Connell AC, Pearson SK, Bowen WH. Pilocarpine alters caries development in partially-desalivated rats. J Dent Res. 1994;73:637\u201343.","journal-title":"J Dent Res"},{"key":"2031_CR7","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/art.39127","volume":"67","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Valdes AM, See LC, Luo SF, Yu KH, et al. Familial risk of Sjogren\u2019s syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study. Arthritis Rheumatol. 2015;67:1904\u201312.","journal-title":"Arthritis Rheumatol"},{"key":"2031_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.1780360309","volume":"36","author":"C Vitali","year":"1993","unstructured":"Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjogren\u2019s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340\u20137.","journal-title":"Arthritis Rheum"},{"key":"2031_CR9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3899\/jrheum.131345","volume":"41","author":"WS Chung","year":"2014","unstructured":"Chung WS, Lin CL, Sung FC, Hsu WH, Chen YF, Kao CH. Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study. J Rheumatol. 2014;41:909\u201315.","journal-title":"J Rheumatol"},{"key":"2031_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3899\/jrheum.141361","volume":"42","author":"CC Shen","year":"2015","unstructured":"Shen CC, Yang AC, Kuo BI, Tsai SJ. Risk of psychiatric disorders following primary Sjogren syndrome: a nationwide population-based retrospective cohort study. J Rheumatol. 2015;42:1203\u20138.","journal-title":"J Rheumatol"},{"key":"2031_CR11","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1503\/cmaj.160783","volume":"189","author":"CC Tseng","year":"2017","unstructured":"Tseng CC, Chang SJ, Tsai WC, Ou TT, Wu CC, Sung WY, et al. Sex differential association of dermatomyositis with Sjogren syndrome. CMAJ. 2017;189:E187\u2013e93.","journal-title":"CMAJ."},{"key":"2031_CR12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/annrheumdis-2012-201593","volume":"72","author":"HH Chen","year":"2013","unstructured":"Chen HH, Huang N, Chen YM, Chen TJ, Chou P, Lee YL, et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis. 2013;72:1206\u201311.","journal-title":"Ann Rheum Dis"},{"key":"2031_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/art.37746","volume":"65","author":"JJ Keller","year":"2013","unstructured":"Keller JJ, Kang JH, Lin HC. Association between ankylosing spondylitis and chronic periodontitis: a population-based study. Arthritis Rheum. 2013;65:167\u201373.","journal-title":"Arthritis Rheum"},{"key":"2031_CR14","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/aje\/kwq224","volume":"172","author":"PC Austin","year":"2010","unstructured":"Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172:1092\u20137.","journal-title":"Am J Epidemiol"},{"key":"2031_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","volume":"54","author":"ST Normand","year":"2001","unstructured":"Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54:387\u201398.","journal-title":"J Clin Epidemiol"},{"key":"2031_CR16","volume-title":"Oral pathology, chapter 2-dental caries","author":"J Soames","year":"1993","unstructured":"Soames J, Southam J. Oral pathology, chapter 2-dental caries; 1993."},{"key":"2031_CR17","volume-title":"Oral and maxillofacial pathology: Elsevier health sciences","author":"BW Neville","year":"2015","unstructured":"Neville BW, Damm DD, Chi AC, Allen CM. Oral and maxillofacial pathology: Elsevier health sciences; 2015."},{"key":"2031_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"FB Vivino","year":"1999","unstructured":"Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL 3rd, Tran-Johnson TK, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med. 1999;159:174\u201381.","journal-title":"Arch Intern Med"},{"key":"2031_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/rheumatology\/41.6.670","volume":"41","author":"J Rosas","year":"2002","unstructured":"Rosas J, Ramos-Casals M, Ena J, Garcia-Carrasco M, Verdu J, Cervera R, et al. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjogren\u2019s syndrome. Correlation with clinical, immunological and histological features. Rheumatology. 2002;41:670\u20135.","journal-title":"Rheumatology"},{"key":"2031_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7525-7-46","volume":"7","author":"B Segal","year":"2009","unstructured":"Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, et al. Primary Sjogren\u2019s syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;7:46.","journal-title":"Health Qual Life Outcomes"},{"key":"2031_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6890-5-4","volume":"5","author":"AM Pedersen","year":"2005","unstructured":"Pedersen AM, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjogren\u2019s syndrome. BMC Clin Pathol. 2005;5:4.","journal-title":"BMC Clin Pathol"},{"key":"2031_CR22","first-page":"699","volume":"31","author":"H Asashima","year":"2013","unstructured":"Asashima H, Inokuma S, Onoda M, Oritsu M. Cut-off levels of salivary beta2-microglobulin and sodium differentiating patients with Sjogren\u2019s syndrome from those without it and healthy controls. Clin Exp Rheumatol. 2013;31:699\u2013703.","journal-title":"Clin Exp Rheumatol"},{"key":"2031_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41232-018-0062-0","volume":"38","author":"N Azuma","year":"2018","unstructured":"Azuma N, Katada Y, Sano H. Deterioration in saliva quality in patients with Sjogren\u2019s syndrome: impact of decrease in salivary epidermal growth factor on the severity of intraoral manifestations. Inflamm Regen. 2018;38:6.","journal-title":"Inflamm Regen"},{"key":"2031_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jdsr.2011.04.002","volume":"47","author":"Y Nakagawa","year":"2011","unstructured":"Nakagawa Y. Management of dry mouth in Sj\u00f6gren\u2019s syndrome. Japanese Dental Science Review. 2011;47:115\u201323.","journal-title":"Japanese Dental Science Review"},{"key":"2031_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12891-017-1543-z","volume":"18","author":"SQ Wang","year":"2017","unstructured":"Wang SQ, Zhang LW, Wei P, Hua H. Is hydroxychloroquine effective in treating primary Sjogren\u2019s syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2017;18:186.","journal-title":"BMC Musculoskelet Disord"},{"key":"2031_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Puechal X, Le Guern V, Sibilia J, Goeb V, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial. JAMA. 2014;312:249\u201358.","journal-title":"JAMA."},{"key":"2031_CR27","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s10067-017-3822-3","volume":"36","author":"J Demarchi","year":"2017","unstructured":"Demarchi J, Papasidero S, Medina MA, Klajn D, Chaparro Del Moral R, Rillo O, et al. Primary Sjogren\u2019s syndrome: extraglandular manifestations and hydroxychloroquine therapy. Clin Rheumatol. 2017;36:2455\u201360.","journal-title":"Clin Rheumatol"},{"key":"2031_CR28","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s10067-018-4233-9","volume":"37","author":"Z Li","year":"2018","unstructured":"Li Z, Fu T, Li L, Cui Y, Dong C, Li J, et al. Prevalence, severity, and predictors of dry eye and dry mouth in Chinese patients with primary Sjogren syndrome. Clin Rheumatol. 2018;37:2971\u20139.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"2031_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/0973-3698.192690","volume":"11","author":"Kavitha Mohanasundaram","year":"2016","unstructured":"Mohanasundaram K, Mani M, Chinnadurai S, Mahendran B, Balaji C, Bhoorasamy A, et al. Study on demography and outcome of extraglandular manifestations of primary Sj\u00f6gren\u2019s syndrome. Indian J Rheumatol. 2016;11:202-6.","journal-title":"Indian Journal of Rheumatology"},{"key":"2031_CR30","first-page":"446","volume":"55","author":"V Valim","year":"2015","unstructured":"Valim V, Trevisani VFM, Pasoto SG, Serrano EV, Ribeiro SLE, de Alencar Fidelix TS, et al. Recommendations for the treatment of Sj\u00f6gren\u2019s syndrome. Revista Brasileira de Reumatologia (English Edition). 2015;55:446\u201357.","journal-title":"Revista Brasileira de Reumatologia (English Edition)"},{"key":"2031_CR31","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.12688\/f1000research.8352.1","volume":"5","author":"Nicholas Holdgate","year":"2016","unstructured":"Holdgate N, St Clair EW. Recent advances in primary Sjogren\u2019s syndrome. F1000Res. 2016;5:1412.","journal-title":"F1000Research"},{"key":"2031_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1067\/moe.2002.120521","volume":"93","author":"KD Hay","year":"2002","unstructured":"Hay KD, Thomson WM. A clinical trial of the anticaries efficacy of casein derivatives complexed with calcium phosphate in patients with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:271\u20135.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2031_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12903-016-0296-7","volume":"16","author":"W Xin","year":"2016","unstructured":"Xin W, Leung KC, Lo EC, Mok MY, Leung MH. A randomized, double-blind, placebo-controlled clinical trial of fluoride varnish in preventing dental caries of Sjogren\u2019s syndrome patients. BMC Oral Health. 2016;16:102.","journal-title":"BMC Oral Health"},{"key":"2031_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.adaj.2015.11.008","volume":"147","author":"DT Zero","year":"2016","unstructured":"Zero DT, Brennan MT, Daniels TE, Papas A, Stewart C, Pinto A, et al. Clinical practice guidelines for oral management of Sjogren disease: dental caries prevention. J Am Dent Assoc. 2016;147:295\u2013305.","journal-title":"J Am Dent Assoc"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-2031-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:32:56Z","timestamp":1606350776000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-2031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2031"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-2031-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"14 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Chang Gung Medical Foundation Institutional Review Board (No. 201801950B1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}